TAKING CANCER PERSONALLY
DEAD

Serial Number

88814224

Owner

NEOGENOMICS LABORATORIES, INC.

Attorney

Anessa O. Kramer

Filing Date

Feb 28, 2020

Add to watchlist:

No watchlists yet
View on USPTO

TAKING CANCER PERSONALLY Trademark

Serial Number: 88814224

TAKING CANCER PERSONALLY is a trademark filed by NEOGENOMICS LABORATORIES, INC. on February 28, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 16 (Paper Goods). The application is currently no longer active.

Owner Contact Info

NEOGENOMICS LABORATORIES, INC. (86 trademarks)

12701 COMMONWEALTH DRIVE, SUITE 9
FORT MYERS, FL 33913

Entity Type: 03

Trademark Details

Filing Date

February 28, 2020

Registration Date

Not Registered

Published for Opposition

February 9, 2021

Goods & Services

Providing online non-downloadable reports to others in the fields of pathology, medical diagnostic testing and oncology testing; education services, namely, providing training and on-demand on-line training in the form of courses, seminars and workshops in the fields of health, health related topics, cancer, cancer pathology, pathology, scientific testing and research services, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; education services, namely, providing non-downloadable webinars in the fields of health, health related topics, cancer, cancer pathology, pathology, scientific testing and research services, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; providing online, non-downloadable reports for others in the fields of medical tests, medical testing, medical research, pathology, diagnostic testing, oncology testing and human disease and medical conditions

Medical tests kits primarily comprised of medical diagnostic reagents and assays for testing body fluids

Printed medical reports in the field of cancer research; printed publications, namely, newsletters and abstracts in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; printed reports for others in the fields of pathology, medical diagnostic testing and oncology testing

Pre-packaged medical tests kits and medical test kits to aid in the diagnosis of disease or cancer, namely, kits primarily composed of DNA probes being biochemical reagents used for detecting and analyzing molecules in protein or nucleotide arrays and also containing clinical medical reagents and antibodies for use in disease testing for clinical medical laboratory use

Medical research; genetic mapping for scientific purposes, namely, gene sequencing; genetic testing and sequencing for scientific purposes; molecular sequencing for scientific purposes; cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells, all being for scientific and/or research purposes; clinical study and testing of cells all being for scientific purposes; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells for scientific or research purposes; medical and scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells, and cancer; providing scientific and/or research information to others in the fields of oncology, pathology and gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells scientific testing and research services and clinical scientific testing; providing an internet website portal featuring gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells all for scientific and/or research purposes; scientific and medical research information in the fields of scientific testing and research services, medical research services, and clinical scientific testing; providing cloud-based scientific and medical research information in the nature of providing temporary use of nondownloadable cloud based software for providing information to others in the field of scientific testing and research services, medical research services, and clinical scientific testing; providing temporary use of online non-downloadable software for analysis of medical test results; temporary use of online non-downloadable software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; non-downloadable computer software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information pertaining to testing and analysis; providing medical research and scientific research information in the field of oncology; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing for scientific purposes in the field of human disease and human medical conditions; clinical laboratory research services, oncology reference laboratory services for research or scientific purposes, providing medical research information and interactive information to others in the fields of medical tests, medical testing, medical research, pathology, diagnostic testing, oncology testing and human disease and medical conditions; providing cloud-based information in the nature of providing temporary use of nondownloadable cloud based software for providing information to others in the field of scientific testing and research, medical research, and clinical scientific testing; providing online non-downloadable Internet-based software for medical testing and analysis of medical test results; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; medical and scientific research, namely, conducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Nov 7, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 7, 2022 ABN6
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 13, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 13, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 13, 2022 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 7, 2022 EXRA
SOU EXTENSION 2 GRANTED
Apr 6, 2022 EX2G
SOU EXTENSION 2 FILED
Apr 4, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 4, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 8, 2021 EXRA
SOU EXTENSION 1 GRANTED
Oct 7, 2021 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 7, 2021 AITU
SOU EXTENSION 1 FILED
Oct 4, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 4, 2021 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 4, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 4, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 4, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 4, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 4, 2021 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 6, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Feb 9, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 20, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 6, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 30, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 30, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 28, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 7, 2020 GNRN
NON-FINAL ACTION E-MAILED
Dec 7, 2020 GNRT
NON-FINAL ACTION WRITTEN
Dec 7, 2020 CNRT
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 7, 2020 GNFN
FINAL REFUSAL E-MAILED
Dec 7, 2020 GNFR
FINAL REFUSAL WRITTEN
Dec 7, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 16, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 16, 2020 CRFA
ASSIGNED TO LIE
Nov 16, 2020 ALIE
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 14, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 14, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 14, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 14, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 14, 2020 COAR
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 14, 2020 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Apr 26, 2020 GPRN
PRIORITY ACTION E-MAILED
Apr 26, 2020 GPRA
PRIORITY ACTION WRITTEN
Apr 26, 2020 CPRA
ASSIGNED TO EXAMINER
Apr 17, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 5, 2020 NWOS
NEW APPLICATION ENTERED
Mar 5, 2020 NWAP